A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma. BJU Int. 2014 May; 113(5b):E137-43.